Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

5.8K
Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

8.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
Riboswitches01:56

Riboswitches

8.2K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
61
GPCR Desensitization01:12

GPCR Desensitization

6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Context-dependent peptide recognition shapes tyrosine kinase substrate specificity beyond consensus motifs.

bioRxiv : the preprint server for biology·2026
Same author

A Hidden Binding Pocket in the β- ketoacyl-ACP Synthase FabB.

bioRxiv : the preprint server for biology·2026
Same author

Developing and Benchmarking Sage 2.3.0 with the AshGC Neural Network Charge Model.

Journal of chemical theory and computation·2026
Same author

Computational design of dynamic biosensors for emerging synthetic opioids.

Nature communications·2026
Same author

Disentangling Metabolite Detection from Pathway Stress Using Biosensors.

ACS synthetic biology·2025
Same author

GOPAL: A Water Model with Improved Thermodynamic Properties over a Large Pressure and Temperature Range Optimized Using Multistate Reweighting and Configuration Space Mapping.

Journal of chemical theory and computation·2025

Related Experiment Video

Updated: Jul 16, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.3K

Biophysical Rationale for the Selective Inhibition of PTP1B over TCPTP by Nonpolar Terpenoids.

Anika J Friedman1, Hannah M Padgette1, Levi Kramer1

  • 1Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80309, United States.

The Journal of Physical Chemistry. B
|September 20, 2023
PubMed
Summary
This summary is machine-generated.

Minor differences in protein structure enable selective inhibition of protein tyrosine phosphatases (PTPs), crucial drug targets for diseases like cancer. This selectivity can be enhanced through chemical modifications of inhibitors.

More Related Videos

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

9.9K
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.6K

Related Experiment Videos

Last Updated: Jul 16, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.3K
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

9.9K
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.6K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Pharmacology

Background:

  • Protein tyrosine phosphatases (PTPs) are key drug targets for various diseases.
  • High structural similarity between PTPs hinders the development of selective inhibitors.
  • Previous work identified terpenoid inhibitors selective for PTP1B over TCPTP.

Purpose of the Study:

  • Investigate the molecular basis for selective inhibition of PTP1B over TCPTP by terpenoids.
  • Utilize molecular modeling and experimental validation to understand selectivity mechanisms.

Main Methods:

  • Molecular dynamics (MD) simulations to analyze protein-protein interactions and binding sites.
  • Experimental validation to support computational findings.
  • Analysis of allosteric networks and key residue interactions.

Main Results:

  • A shared hydrogen bond network connects the active site to an allosteric pocket in both PTP1B and TCPTP.
  • Terpenoid binding can disrupt this network via an alpha or beta site.
  • Selective binding to the alpha site occurs only in PTP1B due to specific charged residues in TCPTP.

Conclusions:

  • Minor amino acid variations at the PTP1B alpha site are responsible for selective inhibitor binding.
  • Chemical modification of inhibitors could enhance this selectivity.
  • Understanding allosteric site conservation is crucial for designing selective PTP inhibitors.